Skip to main content

MediaCenter Panda Security

MediaCenter Panda Security

More than 50% of malware for Android is aimed at stealing from you. Keep an eye on your pocket!

Posted: 30 Jul 2015 01:59 AM PDT

android

With the barrage of news about Hacking Team, the massive cyber espionage by governments, and the US intelligence raids, it might seem that cybercriminals are taking a different route compared to your average criminal. However, don't let this fool you as they are all after the same thing which, as the famous song goes, is "money, money, money".

Wherever there's money, there are sure to be malware creators. So after the boom in internet shopping people are beginning to reach for their pockets to make payments once again; not with their wallets though, but rather their cellphones.

According to a recent study carried out by IAB, 7 out of 10 Spaniards (more than 19 million internet users) regularly buy online. The percentage of those who make purchases from their cellphones or tablets is steadily increasing and currently accounts for 15% of all purchases. In other countries, such as the United States, the percentage of purchases from mobile devices is even greater.

These online purchases generally require the use of sensitive bank information as you are paying with a card or performing a transfer, but this doesn't seem to bother consumers. According to a report by ING, nearly half of Europeans now use their smartphone or tablet to carry out bank transactions.

mobile dollars

Slowly but surely tablets and smartphones are replacing the traditional computer for these types of tasks and, as a result, they have become a goldmine for cybercriminals. Financial malware, designed to gain access to your account, is thriving in the darkest corners of the internet.

More than half of all malware designed for Android has been created with stealing money in mind. This was confirmed by a recent study, which named Trojan and ransomware (which hijacks your terminal and requires a payment to unblock it) as the most popular tools deployed by cybercriminals.

It's interesting to note that it is Android, and not iOS, which is the main target of attack. This is despite iOS taking a far larger profit share of the market. This is because, for the cybercriminals, it is all a matter of volume.

On a global level, Android is a far more popular system and accounts for 78% of the smartphone systems in operation, according to details from the IDC. Meanwhile, iOS only accounts for market share of 18.3%.

The more potential victims there are, the higher the yield for the cybercriminals, as we have seen with the infamous Sypeng and Faketoken cases, which wreaked havoc across the globe. So, if you have already been targeted by them you're in a tricky situation, as prevention is better than the cure in this case.

An antivirus for Android and following some advice when completing transactions on your mobile device (such as avoiding public WiFi connections and avoiding applications that aren't on Google Play) will save you a lot of hassle in the future.

The post More than 50% of malware for Android is aimed at stealing from you. Keep an eye on your pocket! appeared first on MediaCenter Panda Security.

Comments

Post a Comment

Popular posts from this blog

The first drug for a common, deadly liver disease is here – and more are coming

VIEW IN BROWSER | SUBSCRIBE TUE, MAR 19, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good morning!  Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for the condition.    In a landmark decision on Thursday, the Food and Drug Administration approved Madrigal Pharmaceuticals ' drug " Rezdiffra ," to be used along with diet and exercise. The company expects the medicine to be available next month with a hefty price tag of $47,400 per year before insurance and other rebates.    So, why is this approval so important?    First of all, people suffering from the disease badly need a treatment. Rezdiffra is specifically approved to treat patients with...
Post a Comment
Read More

How competitive can Roche be in the weight loss drug market?

VIEW IN BROWSER | SUBSCRIBE TUE, SEP 17, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon!  Roche is one of several drugmakers hoping to join the booming weight loss drug market, which Novo Nordisk and Eli Lilly are currently dominating. But can the Swiss company develop drugs that can compete with that duopoly?  The answer isn't clear yet.  We need to see more data from longer and larger clinical trials, which will likely take years for Roche to conduct.  But the company last week presented more early-stage data more early-stage data on its experimental obesity injection and pill, which some analysts said raised concerns about how competitive those products can be if they enter the space. Some analysts said the new results showed that both drugs – which Roche acquired through its nearly $3 billion acquisition of Carmot Therapeutics in December – c...
Post a Comment
Read More

Successfully unsubscribed from Markets Morning

Dear Reader, As per your request, you have been removed from our mailing list for Markets Morning Get all the updates from the world of business straight to your inbox Getting bigger and stronger. 4 million+ subscribers MANAGE ALL NEWSLETTERS » Daily Newsletter ...
Post a Comment
Read More